Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: Expanding indications and novel combination strategies

Emily Hinchcliff, Shannon Neville Westin, Graziela Dal Molin, Christopher J. Lafargue, Robert L. Coleman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: Expanding indications and novel combination strategies'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science